Search results
Results from the WOW.Com Content Network
The main side effects that could be experienced include mild abdominal pain or diarrhea. [10] The first cholera vaccines were developed in the late 19th century. [16] They were the first widely used vaccines that were made in a laboratory but were largely abandoned in the 1970s due to their then-documented reactogenicity and poor efficacy. [16]
According to the U.S. Centers for Disease Control and Prevention, while "any vaccine can cause side effects", [11] most side effects are minor, primarily including sore arms or a mild fever. [11] Unlike most medical interventions vaccines are given to healthy people, where the risk of side effects is not as easily outweighed by the benefit of ...
The World Health Organization (WHO) has three prequalified oral cholera vaccines (OCVs): Dukoral, Sanchol, and Euvichol. Dukoral, an orally administered, inactivated whole-cell vaccine, has an overall efficacy of about 52% during the first year after being given and 62% in the second year, with minimal side effects. [59]
The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer ...
Vaccines alliance GAVI and UNICEF said last month that the approval of a new cholera vaccine would boost stocks. But the result of the shortage has already been measured in deaths.
The side effects of vaccination are typically minor and go away within a few days. There is a risk that the child could have a severe allergic reaction, but these reactions are rare. However, a decision not to immunize a child also involves risk and could put the child and others who come into contact with him or her at risk of contracting a ...
India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a year amid an expanding ...
The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics. WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week.